The VMAT-2 inhibitor tetrabenazine alters effort-related decision making as measured by the T-maze barrier choice task: reversal with the adenosine A2A antagonist MSX-3 and the catecholamine uptake blocker bupropion
Crossref DOI link: https://doi.org/10.1007/s00213-014-3766-0
Published Online: 2014-10-17
Published Print: 2015-04
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Yohn, Samantha E.
Thompson, Christian
Randall, Patrick A.
Lee, Christie A.
Müller, Christa E.
Baqi, Younis
Correa, Mercè
Salamone, John D.
Text and Data Mining valid from 2014-10-17